Teva Pharmaceutical (TEVA) - News Mentions

Sign up to add (TEVA) to your portfolio and access more historical data.

00%
Est. daily news mentions.
Loading...

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Johnson & Johnson
Johnson & Johnson
JNJ		 0 100%
Eli Lilly and Company
Eli Lilly and Company
LLY		 0 0%
Pfizer
Pfizer
PFE		 1 0%
Astrazeneca
Astrazeneca
AZN		 1 0%
AbbVie
AbbVie
ABBV		 0 0%
Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
January 13
Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
January 12
Truist Lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 From $32
January 10
Bioidentical Hormones Market Size to Reach USD 5.51 Billion by 2033, Driven by Personalized Hormone Therapy Adoption and Rising Menopausal Care Demand – SNS Insider
January 27
Prescription Weight Loss Medications Market Projected to Reach US$ 40.13 Billion by 2035, Supported by Clinical Adoption and Pipeline Expansion Says Astute Analytica
January 26
FRMI SHAREHOLDERS: Fermi Inc. Accused of Misrepresentations about its Customer Agreement in Securities Fraud Class Action – Investors Notified to Contact BFA Law
January 26
CRWV SHAREHOLDERS: CoreWeave, Inc. Accused of Misrepresentations about its Infrastructure in Securities Fraud Class Action – Investors Notified to Contact BFA Law
January 26
BRBR SHAREHOLDERS: BellRing Brands Accused of Misrepresentations about its Growth Drivers in BFA Law’s Securities Fraud Class Action – Investors Notified to Contact the Firm
January 26
BBWI SHAREHOLDERS: Bath & Body Works, Inc. Accused of Misrepresentations about its Growth in Securities Fraud Class Action – Investors Notified to Contact BFA Law
January 26
ARDT SHAREHOLDERS: Ardent Health Accused of Misrepresentations about the Collectability of its Receivables in BFA Law’s Securities Class Action – Investors Urged to Contact the Firm
January 26
ITGR SHAREHOLDERS: Integer Holdings Corporation Accused of Misrepresentations about its Sales Outlook in Securities Fraud Class Action – Investors Notified to Contact BFA Law
January 26
GLP-1 Analogues Market Research 2025-2030: Regulatory Advancements and Sustainability Trends Offer Avenues for Differentiation
January 26
Drugmakers turn to AI to speed trials, regulatory submissions
January 26
CLASS ACTION DEADLINE: Ardent Health, Inc. (NYSE:ARDT) Securities Class Action Deadline is March 9 – Investors Notified to Contact BFA Law about its Filed Lawsuit
January 24
CLASS ACTION INVESTIGATION: Wealthfront Corporation (NASDAQ:WLTH) Securities Investigation is Ongoing – Investors Notified to Contact BFA Law
January 24
CLASS ACTION DEADLINE: Integer Holdings Corporation (NYSE:ITGR) Securities Class Action Deadline is February 9 – Investors Notified to Contact BFA Law about the Filed Lawsuit
January 24

Month over Month

Est. daily news mentions.

Dec 2025 0
Nov 2025 1
Oct 2025 0
Sep 2025 1

How often is Teva Pharmaceutical mentioned in the news?

Teva Pharmaceutical was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Teva Pharmaceutical performing compared to its industry peers?

Teva Pharmaceutical underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Teva Pharmaceutical in the last month?

Teva Pharmaceutical's was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Teva Pharmaceutical?

By monitoring mentions in the news for Teva Pharmaceutical, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Teva Pharmaceutical, ultimately improving their investment strategies.

Sign up and get more insights on Teva Pharmaceutical.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About AltIndex

Smarter investing with alternative data analytics and AI-powered insights.

Download on the App Store Get it on Google Play
Company
Features
More Data
© 2026 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.